• 1. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 2. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 3. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 4. An integrated system for field analysis of Cd(ii) and Pb(ii) via preconcentration using nano-TiO2/cellulose paper composite and subsequent detection with a portable X-ray fluorescence spectrometer?
  Xiaofeng Lin RSC Adv., 2016,6, 9002-9006
• 5. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941

Comprehensive Analysis of 2-Chloro-4-ethoxy-3-fluorophenol (CAS No. 1823779-02-7): Properties, Applications, and Industry Trends

2-Chloro-4-ethoxy-3-fluorophenol (CAS No. 1823779-02-7) is a specialized organic compound gaining attention in pharmaceutical and agrochemical research due to its unique structural features. This halogenated phenol derivative combines chloro, fluoro, and ethoxy functional groups, making it a versatile intermediate for synthesizing complex molecules. The compound's molecular formula, C₈H₈ClFO₂, and precise chemical structure contribute to its reactivity profile, which is currently being explored in drug discovery and crop protection formulations.

Recent studies highlight the growing demand for fluorinated phenolic compounds in medicinal chemistry, with 2-Chloro-4-ethoxy-3-fluorophenol showing promise as a building block for bioactive molecules. Its electron-withdrawing substituents enhance stability while allowing selective modifications—a key requirement for developing targeted therapies. Industry reports indicate increased patent filings involving similar structures for anti-inflammatory and antimicrobial applications, aligning with global health trends.

The synthesis of CAS 1823779-02-7 typically involves multi-step processes including halogenation and etherification reactions. Advanced purification techniques like preparative HPLC ensure high purity (>98%), critical for research applications. Analytical characterization employs NMR spectroscopy (particularly ¹⁹F-NMR) and mass spectrometry, with the compound exhibiting distinct spectral signatures that facilitate quality control.

Environmental considerations have driven innovation in green chemistry approaches for producing such intermediates. Researchers are optimizing solvent systems and catalytic methods to reduce waste generation during 2-Chloro-4-ethoxy-3-fluorophenol synthesis. This aligns with the pharmaceutical industry's focus on sustainable manufacturing—a topic generating substantial search traffic among chemistry professionals.

In material science, derivatives of this compound demonstrate potential for creating specialty polymers with enhanced thermal stability. The ortho-fluorophenol moiety contributes to unique intermolecular interactions, a subject of ongoing studies in advanced material design. Commercial suppliers now offer custom synthesis services for CAS 1823779-02-7, responding to growing R&D requirements across multiple sectors.

Storage and handling protocols for 2-Chloro-4-ethoxy-3-fluorophenol emphasize protection from moisture and light, with recommended conditions below 4°C in amber glass containers. These precautions maintain stability while addressing common researcher queries about compound shelf life—a frequently searched topic in laboratory forums.

Emerging applications include its use as a precursor for fluorescence probes in biochemical assays, leveraging the fluorophenol group's photophysical properties. This connects to trending searches about diagnostic reagents and molecular imaging technologies. The compound's structure-activity relationships are also being investigated for enzyme inhibition effects, particularly in metabolic pathway studies.

Regulatory status varies by region, with proper documentation required for international shipments of 1823779-02-7. Safety data sheets provide essential information on personal protective equipment (PPE) requirements—another high-search-volume topic among laboratory personnel. The compound's physicochemical properties (melting point 72-75°C, logP ~2.3) make it suitable for various formulation developments.

Future research directions may explore computational modeling of this molecule's interactions, a hot topic in cheminformatics communities. The compound's three-dimensional conformation offers interesting possibilities for molecular docking studies, particularly in structure-based drug design—a field generating substantial academic and industrial interest.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)